Skip to main content
Log in

SYNTHESIS, CRYSTAL STRUCTURE, AND BIOLOGICAL EVALUATION OF (E)-1-(4-(4-BROMOBENZYL)PIPERAZIN-1-YL)- 3-(4-CHLOROPHENYL)PROP-2-EN-1-ONE

  • Published:
Journal of Structural Chemistry Aims and scope Submit manuscript

Abstract

Title compound (E)-1-(4-(4-bromobenzyl)piperazin-1-yl)-3-(4-chlorophenyl)prop-2-en-1-one (5) (C20H20BrClN2O, Mr = 419.74) is designed, synthesized, and evaluated for its biological activity. Its structure is confirmed by FTIR, 1H and 13C NMR, HRMS, and X-ray single crystal diffraction. The structure is stabilized via inter- as well as intra- C–H…O interactions and intra hydrogen bonding C–H…N interactions. The Hirshfeld surface intermolecular interactions are studied using the crystal structure. The maximum surface area of the molecule is occupied by C–H…O interactions. In addition, the biological activity in vitro and in vivo of title compound 5 is also evaluated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Scheme 1
Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

REFERENCES

  1. R. W. V. Flynn, R. S. M. MacWalter, and A. S. F. Doney. Neuropharmacology, 2008, 55, 250–256.

  2. J. D. Pandian, V. Padma, P. Vijaya, P. N. Sylaja, and J. M. K. Murthy. Int. J. Stroke, 2007, 2, 17–26.

  3. D. W. Choi. Neuron, 1988, 1, 623–634.

  4. C. Lv, X. Yuan, H. W. Zeng, R. H. Liu, and W. D. Zhang. Eur. J. Pharmacol., 2017, 815, 487–494.

  5. K. Uchino. JAMA Neurol., 2017, 74, 1269.

  6. N. R. Mohan, S. Sreenivasa, K. E. Manojkumar, T. M. C. Rao, B. S. Thippeswamy, and P. A. Suchetan. J. Braz. Chem. Soc., 2014, 25, 1012–1020.

  7. M. Han, Y. Han, C. Song, and H. G. Hahn. Bull. Korean Chem. Soc., 2012, 33, 2597–2602.

  8. L. L. Gan, J. L. Cai, and C. H. Zhou. Chin. Pharm. J., 2009, 44, 1361–1368.

  9. L. L. Gan, Y. H. Lu, and C. H. Zhou. Chin. J. Biochem. Pharm., 2009, 30, 127–131.

  10. V. R. Solomon, C. Hu, and H. Lee. Bioorg. Med. Chem., 2010, 18, 1563–1572.

  11. M. Kimura, T. Masuda, K. Yamada, N. Kawakatsu, N. Kubota, M. Mitani, K. Kishii, M. Inazu, Y. Kiuchi, K. Oguchi, and T. Namiki. Bioorg. Med. Chem. Lett., 2004, 14, 4287–4290.

  12. L. A. Shapiro, S. J. Offord, and G. A. Ordway. Brain Res., 1995, 677, 250–260.

  13. C. Yang, G. Xu, J. Li, X. Wu, B. Liu, X. Yan, M. Wang, and Y. Xie. Bioorg. Med. Chem. Lett., 2005, 15, 1505–1507.

  14. B. Qin, M. Nagasaki, M. Ren, G. Bajotto, Y. Oshida, and Y. Sato. Diabetes Res. Clin. Pract., 2003, 62, 139–148.

  15. D. M. Cheng, P. Kuhn, A. Poulev, L. E. Rojo, M. A. Lila, and I. Raskin. Food Chem., 2012, 135, 2994–3002.

  16. D. Fancelli, A. Abate, R. Amici, P. Bernardi, M. Ballarini, A. Cappa, G. Carenzi, A. Colombo, C. Contursi, F. D. Lisa, G. Dondio, S. Gagliardi, E. Milanesi, S. Minucci, G. Pain, P. G. Pelicci, A. Saccani, M. Storto, F. Thaler, M. Varasi, M. Villa, and S. Plyte. J. Med. Chem., 2014, 57, 5333–5347.

  17. G. M. Sheldrick. SHELXS-97, SHELXL-97 and SADABS, Version 2.05. University of Göttingen: Göttingen, Germany, 1997.

  18. F. L. Hirshfeld. Theor. Chim. Acta, 1977, 44, 129–138.

  19. J. J. McKinnon, A. S. Mitchell, and M. A. Spackman. Chem. Eur. J., 1998, 4, 2136–2141.

  20. S. K. Wolff, D. J. Grimwood, J. J. McKinnon, M. J. Turner, D. Jayatilaka, M. A. Spackman. CrystalExplorer, Version 3.1. University of Western Australia: Perth, Australia, 2012.

  21. M. A. Spackman and D. Jayatilaka. CrystEngComm, 2009, 11, 19–32.

  22. M. A. Spackman and J. J. McKinnon. CrystEngComm, 2002, 4, 378–392.

  23. A. Akaike, Y. Tamura, Y. Sato, and T. Yokota. Eur. J. Pharmacol., 1993, 241, 1–6.

  24. S. W. Ma, H. X. Liu, H. Y. Jiao, L. Y. Wang, L. Y. Chen, J. Liang, M. Zhao, and X. T. Zhang. NeuroToxicology, 2012, 33, 59–69.

  25. T. Mosmann. J. Immunol. Methods, 1983, 65, 55–63.

  26. T. Terauchi, T. Doko, M. Yonaga, A. Kajiwara, T. Niidome, R. Taguchi, T. Kume, A. Akaike, and H. Sugimoto. Bioorg. Med. Chem. Lett., 2006, 16, 5080–5083.

  27. Y. Y. Zhang, X. Y. Wang, X. R. Wang, Z. H. Xu, Z. Liu, Q. Ni, X. P. Chu, M. F. Qiu, A. H. Zhao, and W. Jia. J. Ethnopharmacol., 2006, 108, 355–360.

  28. R. Rodolfo, R. R. Isela, L. S. Darwin, V. Horacio, H. Enrique, M. Martha, and H. Ismael. J. Stroke Cerebrovasc. Dis., 2000, 9, 45–53.

  29. M. Li, L. R. Wen, W. J. Fu, F. Z. Hu, and H. Z. Yang. Chin. J. Struct. Chem., 2004, 23, 11–14.

  30. K. S. Saikat. CrystEngComm, 2013, 15, 1772–1781.

  31. K. S. Saikat. J. Mol. Struct., 2014, 1064, 70–75.

  32. K. Ohnuma, Y. Hayashi, M. Furue, K. Kaneko, and M. Asashima. J. Neurosci. Methods, 2006, 151, 250–261.

  33. H. R. Wang, B. Shao, H. Y. Yu, F. B. Xu, P. Y. Wang, K. Y. Yu, Y. F. Han, M. Song, Y F. Li, and Z. Cao. Chem. Biol. Interact., 2019, 299, 15–26.

Download references

Funding

This research was supported by the Natural Science Foundation of China Grant (81371451) and the Natural Science Foundation of Jiangsu Province Grant (BK20131390).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Y. Zhong or B. Wu.

Ethics declarations

The authors declare that they have no conflict of interests.

Additional information

Text © The Author(s), 2021, published in Zhurnal Strukturnoi Khimii, 2021, Vol. 62, No. 3, pp. 511-520.https://doi.org/10.26902/JSC_id69939

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, L.Y., Yang, C.Z., Xu, Y. et al. SYNTHESIS, CRYSTAL STRUCTURE, AND BIOLOGICAL EVALUATION OF (E)-1-(4-(4-BROMOBENZYL)PIPERAZIN-1-YL)- 3-(4-CHLOROPHENYL)PROP-2-EN-1-ONE. J Struct Chem 62, 481–490 (2021). https://doi.org/10.1134/S002247662103015X

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S002247662103015X

Keywords

Navigation